Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 528-534

  Magen, Iddo ^a   Avraham, Yosefa ^a   Ackerman, Zvi ^b   Vorobiev, Lia ^a   Mechoulam, Raphael ^b   Berry, Elliot M ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Activity; Bile duct ligation; Cognition; Gene expression; Inflammation

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2 RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIDIOL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CHRONIC LIVER DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; LOCOMOTION; MAZE TEST; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; BILE DUCTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CANNABIDIOL; CHRONIC DISEASE; COGNITION; COGNITION DISORDERS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; FEMALE; GAIT DISORDERS, NEUROLOGIC; HEPATIC ENCEPHALOPATHY; LIGATION; LIVER DISEASES; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; RECEPTOR, ADENOSINE A2A; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TREATMENT OUTCOME; TRIAZINES; TRIAZOLES;

EID: 68049129534     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.04.021     Document Type: Article

References (43)

1. Kountouras J., Billing B.H., and Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65 (1984) 305-311
2. Liu K.Z., Man A., Shaw R.A., Liang B., Xu Z., and Gong Y. Molecular determination of liver fibrosis by synchrotron infrared microspectroscopy. Biochim Biophys Acta 1758 (2006) 960-967
3. Huang L.T., Hsieh C.S., Chou M.H., Chuang J.H., Liou C.W., Tiao M.M., et al. Obstructive jaundice in rats: cause of spatial memory deficits with recovery after biliary decompression. World J Surg 28 (2004) 283-287
4. Montes S., Alcaraz-Zubeldia M., Muriel P., and Rios C. Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res 891 (2001) 123-129
5. Kerfoot S.M., D'Mello C., Nguyen H., Ajuebor M.N., Kubes P., Le T., et al. TNF-α secreting monocytes are recruited into the brain of cholestatic mice. Hepatology 43 (2006) 154-162
6. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
7. Wu C.W., Chen Y.C., Yu L., Chen H.I., Jen C.J., Huang A.M., et al. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J Neurochem 103 (2007) 2471-2481
8. Feng R., Rampon C., Tang Y.P., Shrom D., Jin J., Kyin M., et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32 (2001) 911-926
9. Stella N. Cannabinoid signaling in glial cells. Glia 48 (2004) 267-277
10. Devane W.A., Hanuš L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
11. Mechoulam R., Ben-Shabat S., Hanuš L., Ligumsky M., Kaminski N.E., Schatz A.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50 (1995) 83-90
12. Van der Stelt M., and Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat 77 (2005) 111-122
13. 2 receptors in human brain inflammation. Br J Pharmacol 153 (2008) 277-285
14. Avraham Y., Israeli E., Gabbay E., Okun A., Zolotarev O., Silberman I., et al. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol Dis 21 (2006) 237-245
15. Dagon Y., Avraham Y., Ilan Y., Mechoulam R., and Berry E.M. Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J 21 (2007) 2431-2441
16. Pacher P., Bátkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006) 389-462
17. Mallat A., and Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am J Physiol Gastrointest Liver Physiol 294 (2008) G9-G12
18. 2 receptor agonists in vitro. Br J Pharmacol 150 (2007) 613-623
19. Mechoulam R., Peters M., Murillo-Rodriguez E., and Hanuš L.O. Cannabidiol - recent advances. Chem Biodivers 4 (2007) 1678-1692
20. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97 (2000) 9561-9566
21. Ben-Shabat S., Hanuš L.O., Katzavian G., and Gallily R. New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity. J Med Chem 49 (2006) 1113-1117
22. 2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 994-999
23. Hanuš L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., et al. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96 (1999) 14228-14233
24. Pick C.G., and Yanai J. Eight arm maze for mice. Int J Neurosci 21 (1983) 63-66
25. Hao S., Avraham Y., Bonne O., and Berry E.M. Separation-induced body weight loss, impairment in alternation behavior, and autonomic tone: effects of tyrosine. Pharmacol Biochem Behav 68 (2001) 273-278
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 6 (1979) 65-70
27. Shawcross D.L., Davies N.A., Williams R., and Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40 (2004) 247-254
28. Patrignani P., Tacconelli S., Sciulli M.G., and Capone M.L. New insights into COX-2 biology and inhibition. Brain Res Brain Res Rev 48 (2005) 352-359
29. Cauli O., Rodrigo R., Piedrafita B., Boix J., and Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46 (2007) 514-519
30. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 26 (2006) 9703-9712
31. Gourevitch R., Rocher C., Le Pen G., Krebs M.O., and Jay T.M. Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15 (2004) 287-292
32. Barde Y.A., Edgar D., and Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1 (1982) 549-553
33. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341 (1989) 149-152
34. Mizuno M., Yamada K., Takei N., Tran M.H., He J., Nakajima A., et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 8 (2003) 217-224
35. Chan J.P., Cordeira J., Calderon G.A., Iyer L.K., and Rios M. Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampus. Mol Cell Neurosci 39 (2008) 372-383
36. Carrier E.J., Auchampach J.A., and Hillard C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 103 (2006) 7895-7900
37. 2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs 14 (2005) 797-806
38. 2A receptor activation by endogenous adenosine. Neuropharmacology 54 (2008) 924-933
39. 2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24 (2004) 2905-2913
40. 2A receptors. Hippocampus 17 (2007) 577-585
41. Tebano M.T., Martire A., Potenza R.L., Grò C., Pepponi R., Armida M., et al. Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J Neurochem 104 (2008) 279-286
42. 2A receptor knock-outs. J Neurosci 28 (2008) 2970-2975
43. Avraham Y., Zolotarev O., Grigoriadis N.C., Pautahidis T., Magen I., Vorobiav L., et al. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol 103 (2008) 3047-3056